Top Section/Ad
Top Section/Ad
Most recent
M&A could be much needed shot in the arm but dollars expected to dominate
Deal includes $1bn 3.75 year term loan
The German pharmaceutical wholesaler was upgraded to BBB- by S&P last month
US drug company Eli Lilly jolted the dollar market awake on Wednesday with an eight-part jumbo trade to fund two recent acquisitions
More articles/Ad
More articles/Ad
More articles
-
Major shareholder reduces stake in Spanish pharmaceuticals company -
Saudi Arabia’s IPO market is thriving amid the turmoil caused by Russia’s invasion of Ukraine
-
Boston Scientific plans four tranche deal as European issuers hang back
-
Volatility has become the norm in the US high grade new issue market
-
Swiss market debates whether it has found new limits or cannot support multiple monster trades after biggest deal in 13 years
-
Despite a booming market for real estate investment trusts, Impact Healthcare Reit has reduced the size of its latest capital increase by 20%
